Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
Harry Bartelink(Radboud University Nijmegen), M. Piérart(Unknown), I. Barillot(Université de Tours), H. Struikmans(Radboud University Nijmegen), Alain Fourquet(Institut Curie), Laurence Collette(GlaxoSmithKline (Belgium)), J.J. Jager(Radboud University Nijmegen), Walter Van den Bogaert(Radboud University Nijmegen), W.J. Hoogenraad(Radboud University Nijmegen), Jean-Claude Horiot(Radboud University Nijmegen), Jacques Borger(The Netherlands Cancer Institute), Philip Poortmans(University of Antwerp)
Cited by 950
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k